B

Bolden Therapeutics

8 employees

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics

Date founded

2019

Funding rounds raised

Total raised

$800K

from 1 investors over 1 rounds

B

Bolden Therapeutics raised $800K on October 15, 2021

Investors: PARTNERS RESOLUTE

FAQ